Michael J Lazarus MD
CIK 1219782 · View on SEC EDGAR ↗
First SEC filing: Jan. 9, 2006 · Latest: Jan. 9, 2006
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 15, 2005 | NVAX | S | 10,000 | $4.40 | $44,000 | 11,927 Direct | -45.61% | Disposed | -90.5% (price as of 2026-08-20) |
| Jan. 23, 2003 | NVAX | P | 1,445 | $3.17 | $4,581 | 11,927 Direct | +13.79% | Acquired | -86.8% (price as of 2026-08-20) |
| Aug. 22, 2001 | NVAX | P | 482 | $13.55 | $6,531 | 11,927 Direct | +4.21% | Acquired | -96.9% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 17, 2006 | NVAX | Option | Common (15,000) | $4.60 | Feb. 17, 2016 | 15,000 | Acquired |
| Dec. 15, 2005 | NVAX | Stock Option Right-to-Buy | Common (10,000) | $3.75 | Dec. 29, 2005 | 10,000 | Disposed |
| May 4, 2005 | NVAX | Option (1) | Common (15,000) | $1.48 | May 4, 2015 | 15,000 | Acquired |
| March 9, 2004 | NVAX | Right-To-Buy | Common (20,000) | $5.95 | March 9, 2014 | 20,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).